Cytodyn Inc (CYDY)

[daemon57]

Just out for BMS approval for Bristol Myers Squibb:

"FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer"

"Opdivo is a monoclonal antibody that inhibits tumor growth by enhancing T-cell function. Its efficacy was evaluated in a randomized, multicenter, open-label trial of 1,581 patients with previously untreated advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma. The 789 patients who received Opdivo in combination with chemotherapy, on average, lived longer than the 792 patients who received chemotherapy alone. Median survival was 13.8 months for patients who received Opdivo plus chemotherapy compared to 11.6 months for patients who received chemotherapy alone."

If I remember correctly, didn't SK mention LL had someone survive 2 years or double chemo?? If that's the case, we ARE WELL ahead of the pack in terms of mortality...... ONCOLOGY, HERE WE COME.

GLTU/A.